Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

Item

http://www.wikidata.org/entity/Q34222890

Q34222890

about

Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable Stage IV colorectal cancer How to Create Evidence for the Integration of Local and Locoregional Treatments in Future Oncological Treatment Concepts?Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysis Management of asymptomatic primary tumours in stage IV colorectal cancer: Review of outcomes.The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer.Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?Insights into surgical trials: methodological challenges and solutions.Impact of resection versus no resection of the primary tumor on survival in patients with colorectal cancer and synchronous unresectable metastases: protocol for a randomized multicenter study (CR4).Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study.From tumour heterogeneity to advances in precision treatment of colorectal cancer.Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study.Improved survival of colorectal cancer in Denmark during 2001-2012 - The efforts of several national initiatives.Primary Tumor Resection and Multimodality Treatment for Patients with Metastatic Colon Cancer.Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases.Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.[Multimodal treatment of colorectal liver metastases].Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model.Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.Benefit of Surgical Resection of the Primary Tumor in Patients Undergoing Chemotherapy for Stage IV Colorectal Cancer with Unresected Metastasis.Palliative surgical intervention in metastatic colorectal carcinoma: a prospective analysis of quality of life.Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.[Metastasized colonic cancer. When are there no indications for primary resection?].Trends and predictors of resection of the primary tumor for patients with stage IV colorectal cancer.

P2860

Q24201610-AF221226-E9D4-4315-BB4A-C7F3D39D2079 Q26796520-A5A2B61E-ED0E-48D6-AEA3-13200901A1A9 Q31168985-15083458-0E91-41F2-BF79-B787EDA2AD62 Q33669034-8626FF38-A1D8-453A-A67B-6D7D67E5AA3A Q36369856-FDB3ECC2-8919-4271-A543-D70410E11E29 Q36859868-85316ECA-F5D4-426B-AD9F-FAE50C3B9ED8 Q37633038-96B6DEA2-E686-4537-85FA-3CE366B04C2F Q38179306-862E838D-17CB-4865-B897-360DB14325E8 Q38376890-1A4E1B44-89F7-43EF-8BC8-F49A0DCB47B9 Q38635306-F36FABC9-4920-4F7B-B92E-ACBC04D4F145 Q38786707-460619F3-EEEF-4CDB-B358-5740872F1CFB Q38904430-2DA1E4FB-C6D0-4013-87BC-48AA6571E613 Q38951116-151C8E8F-DAFC-48E9-84DC-7D3984AEC35C Q39154892-52AE42B7-E825-4E54-9D7D-CE84BD3FE009 Q40011336-86CC6F13-1054-4514-B3D6-70BDB32FD584 Q40087643-BBDF5C38-BA8F-4AAD-B423-642E5ACF2957 Q40257417-E1B058D3-25C5-4547-B67B-16016E46F2CC Q40682861-6A2DA8F2-A823-4316-B2D9-02275D8E4F40 Q41149600-0D1662A6-1D20-421B-A04A-9E554549595B Q41469105-F781B799-B482-4D0D-AEAF-3CB3563A41B3 Q42263453-38C12733-6693-4220-9A57-DD902316F5E1 Q42374201-6C75D654-3861-4F96-BA84-3DF5D0B814DF Q47619749-60E2FB57-A791-4EF2-8C30-0C058D400BC4 Q47636393-7CBC6D4E-2BA9-47E1-ACA8-1AD565C09A89 Q48094105-CF1040BA-23DB-41A4-9983-22B3CEB09DB1 Q53087607-BC61A66B-C8FF-4BA2-AE16-03A9467A2B6B Q53147876-48891516-8DE4-4BA5-AC04-97E1BED50AFD Q53524485-BFBC2136-0472-44F1-82BD-7AEED25F45EA

P2860

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

Item

http://www.wikidata.org/entity/Q34222890

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Resection of the primary tumou ...... centre trial (ISRCTN30964555).

@ast

Resection of the primary tumou ...... centre trial (ISRCTN30964555).

@en

Resection of the primary tumou ...... ronous unresectable metastases

@nl

type

Item

label

Resection of the primary tumou ...... centre trial (ISRCTN30964555).

@ast

Resection of the primary tumou ...... centre trial (ISRCTN30964555).

@en

Resection of the primary tumou ...... ronous unresectable metastases

@nl

prefLabel

Resection of the primary tumou ...... centre trial (ISRCTN30964555).

@ast

Resection of the primary tumou ...... centre trial (ISRCTN30964555).

@en

Resection of the primary tumou ...... ronous unresectable metastases

@nl

P1476

Resection of the primary tumou ...... centre trial (ISRCTN30964555).

@en

P2093

Annika Stange

http://www.w3.org/2001/XMLSchema#string

Christine Fink

http://www.w3.org/2001/XMLSchema#string

Dirk Jäger

http://www.w3.org/2001/XMLSchema#string

Florian Lordick

http://www.w3.org/2001/XMLSchema#string

Inga Rossion

http://www.w3.org/2001/XMLSchema#string

Moritz Koch

http://www.w3.org/2001/XMLSchema#string

Nuh N Rahbari

http://www.w3.org/2001/XMLSchema#string

SYNCHRONOUS trial group

http://www.w3.org/2001/XMLSchema#string

Stefan Englert

http://www.w3.org/2001/XMLSchema#string

Steffen P Luntz

http://www.w3.org/2001/XMLSchema#string

P2860

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit

Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000.

Initial presentation with stage IV colorectal cancer: how aggressive should we be?

Guidelines 2000 for colon and rectal cancer surgery.

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic O

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

P2888

1471-2407-12-142

P304

142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-12-142

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jürgen Weitz

Meinhard Kieser

Markus Büchler

P577

2012-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223961750

http://www.w3.org/2001/XMLSchema#string

P6179

1010579382

http://www.w3.org/2001/XMLSchema#string

P698

22480173

http://www.w3.org/2001/XMLSchema#string

P921

patient

multicenter trial

P932

3348093

http://www.w3.org/2001/XMLSchema#string

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

about

P2860

P2860

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P921

P932